Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 28, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Chapare virus: A new Arenavirus threat to mankind

COMMON SEASONAL CORONAVIRUSES DOESN’T OFFER ANY PROTECTION-FIND OUT!

Amity Institute of Microbial Technology Life Science JRF Job Opening

Chapare virus: A new Arenavirus threat to mankind
  • BiotechToday
  • World

Chapare virus: A new Arenavirus threat to mankind

bioxone November 23, 2020November 22, 2020

Sayak Banerjee, Amity University Kolkata

According to the American Society of Tropical Medicine and Hygiene (ASTMH), The US Centers for Disease Control and Prevention (CDC) discovered a deadly virus, named Chapare virus that caused more than five infections near Bolivia’s capital city, La Paz, out of which three are fatal.  The researchers attested that the virus can be carried by a species of rodents and spread to humans and animals causing infection.      

Caitlin Cossaboom, an epidemiologist with the CDC corroborated that two health care workers along with a patient had caught the virus and died after dealing with some of the infected patients. She confirmed the human-to-human transmission of the virus and that it could be carried by many bodily fluids. Utmost care should be taken by the health care workers or anyone else while dealing with these cases as contact with blood, urine, saliva and semen contamination might transmit the virus. 

Chapare virus falls under the arenavirus family and can cause hemorrhagic fevers similar to Ebola disease. Besides fever the other significant symptoms could be vomiting, abdominal pain, skin rash, bleeding gums and pain behind the eyes.  Cossaboom confirmed that rodents are the ultimate source of these viruses. After isolating the genome sequence of the RNA in rodent specimens which were similar to that in the infected humans, pigmy rice rat and the small-eared pigmy rice rat, found across Bolivia and several neighbouring countries, were tested positive for the viral RNA. Although this does not prove that the rodents were infectious, it provides a major indication.

Similar to the diagnosis for COVID-19, the CDC experts developed RT-PCR test for detecting Chapare. They were able to distinguish the virus as Chapare because its matched sequence data obtained from the patient involved in the 2004 infection.

There are many things yet to be resolved, especially its origin, how it infects human and whether such huge outbreaks in Bolivia are elsewhere in South America. Scientists believe that Chapare virus might have been circulating in Bolivia for some years, but inaccurate treatment has been administered to the infected patients, stating it as suffering from dengue, which has similar symptoms and is usual in that region. 

Also read: Engineered antibody: Potential cure to COVID – 19?

Source:

https://scitechdaily.com/chapare-virus-evidence-shows-human-transmission-in-deadly-outbreakofmysterious-disease/

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Arenavirus Chapare Virus COVID-19 Ebola genome sequence hemorrhagic fever HFV human-to-human transmission Infectious disease next-generation sequencing RT-PCR viral RNA virology

One thought on “Chapare virus: A new Arenavirus threat to mankind”

  1. Pingback: CAR-T FOR CARCINOMA- THE GAME CHANGER IN CANCER TREATMENT - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Amity Institute of Microbial Technology Life Science JRF Job Opening

bioxone November 23, 2020

-Shristi Sharma, Team bioXone AIMT Amity JRF Job – Life Science Apply Online. Amity Institute of Microbial Technology, Amity University, Noida Vacancy. Amity University, Noida, JRF Job Opening. MSc Life Science applicants apply. Interested and eligible candidates check below: View Notification Amity Vacancy Details  Adv/AUUP/HR/20/061 Advertisement Date: 19-11-2020 Name of Post: Junior Research Fellow No. […]

Related Post

  • BiotechToday
  • World

Neuropilin-1 (NRP-1) influencing SARS-CoV-2 to infect human cells more abruptly

bioxone October 22, 2020October 22, 2020

Devyani Goswami, Amity University Kolkata The spike proteins of the SARS-CoV-2 have been always the subject of interest in how it attaches to the human cells and causes the disease. Angiotensin-converting enzyme 2 (ACE2) is identified as the functional receptor for SARS-CoV (the virus observed in 2003); they are present in the epithelia of the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Diallyl Trisulfide: A potent antiviral against H9N2 Influenza

BioTech Today August 26, 2021August 26, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi Influenza is a serious respiratory infection that causes a significant amount of morbidity and mortality. Annually, it is estimated that 290,000–650,000 people die from influenza. There are currently two kinds of anti-influenza virus therapeutic options: M2 channel blockers and neuraminidase inhibitors. However, the clinical utility of these medicines […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

NEW INSIGHTS INTO MALARIA VECTOR IN LAOS COUNTRY

bioxone October 19, 2020October 18, 2020

Aishila Kar, Amity University Kolkata Malaria is the deadliest vector-borne disease worldwide with an average of 228 million cases, and 405,000 deaths in 2018, mainly in the African Region (93%), and the South-East Asia Region (3.4%). In Laos, the malaria burden remains despite a significant reduction of cases during the last decade. In the condition […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy